IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Go back to IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies| (NASDAQ: INAB) | Delayed: 1.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.43 | EPS | $ | |||
| Volume | 311 | |||||

